Tallac Therapeutics
0 followers
Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a poten... Read more
Org chart
Hong I. Wan
President, Chief Executive Officer and Co-Founder
Hong I. Wan
Collapse
Bora Han
Vice President, Preclinical Development
Curtis Hecht
Chief Business Officer
Em Abellana
Senior Director Finance
Janet Sim 沈彬
VP Biologics Discovery and Development
Kevin N. Heller
Chief Medical Officer
Mark Karbarz
Executive Director of Biologics Development, Head of CMC
Pavel Strop
Vice President, Head of Research
Peter Dudek
Board Director
Kimberli Brill
Vice President, Clinical Sciences
